PROCR and Genetic thrombotic microangiopathy: In this light, pigs have been engineered to express human thrombomodulin and endothelial cell protein receptor C (EPCR) to reduce coagulative incompatibilities and thrombotic microangiopathy often observed in rejected kidney and heart xenografts [28].